Deep Tech Startups

CUbIQ Technologies develops quantum communication technology, including quantum key distribution (QKD) demonstrated in a QSFP-28 pluggable form factor. The Dutch company works in the quantum cryptography and secure communications field.

1 investor

Cuebench builds reinforcement learning environments focused on scientific reasoning, experiment design, and performance/inference engineering, targeting tasks where frontier AI models still fail most of the time. Its environments are used to train and improve AI models on specialized capabilities.

1 investor

Cultured Computer is a research lab studying how to give AI a continuous sense of context and consistent persona so that interactions feel human and stay coherent. Its work spans social psychology, cognitive architectures, world models, and context engineering for AI that adapts to the people it serves.

1 investor

CUPP is an investment or advisory firm whose team combines technology expertise, industry knowledge, and investment experience, operating globally with locations in California and Norway.

1 investor

Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.

1 investor

CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.

1 investor

Curia provides R&D and manufacturing services to help clients address complex scientific and production challenges. The company employs over 3,000 scientists and specialists across 20 global locations.

1 investor

Curida is a contract manufacturing organization specializing in pharmaceutical liquid formulations and biologics, operating under strict EU GMP and ISO certifications to ensure product quality and compliance. The company serves pharmaceutical companies and life science organizations requiring manufacturing and technology transfer services.

1 investor

Curvalux develops multi-beam phased array antenna systems for low-power, long-range fixed wireless access, delivering fiber-like broadband speeds over WiFi and 5G to underserved and rural areas. The technology targets mobile operators and telecommunications companies seeking to extend broadband coverage without the cost and power demands of 4G/5G tower infrastructure.

1 investor

CustomSurg develops digital solutions for orthopaedic trauma surgery, combining clinical expertise with data science and advanced technology. The company serves surgeons and clinical institutions globally.

1 investor

Cutanos is a biotechnology company developing a Langerhans Cell Targeted Delivery System (LC-TDS) that uses a langerin-specific glycomimetic ligand to direct lipid nanoparticle and mRNA/protein formulations to specific skin-resident dendritic cells for vaccines and immunotherapies. The platform is administered via minimally invasive microneedles or microinjectors and targets next-generation vaccines, cancer immunotherapy, and autoimmune disease applications.

1 investor

CY Vision builds 3D augmented-reality head-up display (AR HUD) technology for vehicles, delivering true 3D imagery across multiple depth planes with a wide field of view while running on existing vehicle compute and sensor systems. Its displays target automakers across compact cars, SUVs, and commercial trucks to reduce eyes-off-road time and highlight hazards, lane markers, and signage.

1 investor

Cyanomin develops a biological desalination process that uses bacteria with electrically charged biofilms to adsorb and remove ions from hypersaline brines, treating wastewater without membranes, pressure, or heat. It serves industries that generate hypersaline wastewater, including oil & gas, lithium and copper extraction, and seawater desalination.

1 investor

An accelerator and venture capital program focused on cybersecurity companies, emphasizing founder development and market validation through feedback from industry experts and security leaders.

1 investor

Cyberwave provides an infrastructure platform that abstracts robots, sensors, and autonomous systems behind universal APIs, with digital twins for simulation and orchestration tools to deploy and manage device fleets through code. It serves developers and enterprises building on physical systems across robotics, autonomous navigation, sensor fusion, and edge AI.

1 investor

Cyclarity Therapeutics develops engineered cyclodextrin drugs that target and remove toxic oxidized cholesterol (7-ketocholesterol) to treat atherosclerosis and other age-related diseases. Its lead candidate, UDP-003, is a preclinical/early clinical therapy aimed at cardiovascular disease, with additional pipeline programs for stroke recovery, Alzheimer's, and other conditions.

1 investor

Cyclicor is a biotechnology company based in Lund, Sweden that develops sustainable alternatives for plastics and coatings. The company focuses on transitioning the chemical industry toward circular economy solutions.

1 investor

Cycuity provides security verification solutions for semiconductor chips to detect and mitigate hardware vulnerabilities during the development lifecycle before manufacturing. The company serves semiconductor manufacturers and design organizations seeking to prevent cyberattacks targeting chip-level hardware.

1 investor

Cyndr offers a capability intelligence platform that maps organisations, research activity, and technologies across national security and emerging technology ecosystems. It helps investors—including venture capital firms, strategic investors, and government-backed innovation funds—discover emerging companies, evaluate technology relevance, and monitor developments across defence, intelligence, and national security domains.

1 investor

Cytecom develops a rapid diagnostic technology that detects viable bacteria in under a minute using a patented method of Optical Electrophysiology, combining fluorescent microscopy with electrical stimulation. The technology is aimed at addressing antimicrobial resistance through faster antibiotic susceptibility testing.

1 investor

CyteSi builds a semiconductor-based Bio Processing Unit (BPU) that creates a software-defined wet lab, using a programmable continuous-flow system to automate liquid-handling workflows such as NGS library prep, drug discovery, and reagent synthesis. The platform is aimed at labs and AI-driven research teams seeking high-throughput physical validation with reduced reagent use.

1 investor

Cytomos develops AuraCyt®, a microelectronics-based biotechnology platform for real-time single-cell analytics in bioprocessing and cell and gene therapy manufacturing. The company serves large biotech and pharma companies seeking cost-effective process analytical technology solutions for drug development and manufacturing.

1 investor

Cyto Recovery develops technology for label-free cell sorting and gentle sample cleanup for cell populations, aimed at life-science and research users. Its products are positioned as tools for separating and purifying cells without labeling.

1 investor

Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake. It serves therapeutic developers seeking to deliver treatments such as mRNA-based therapies beyond the liver.

1 investor